BACKGROUND: Mechanical ventilation is a common and often life-saving intervention in intensive care medicine. About 35% of all patients in intensive care are mechanically ventilated; about 15% of these patients develop a ventilation-associated pneumonia. The goal of ventilation therapy is to lessen the work of respiration and pulmonary gas exchange and thereby maintain or restore an adequate oxygen supply to the body's tissues. Mechanical ventilation can be carried out in many different modes; the avoidance of ventilation-induced lung damage through protective ventilation strategies is currently a major focus of clinical interest. METHOD: This review is based on pertinent articles retrieved by a selective literature search. RESULTS: Compared to conventional lung-protecting modes of mechanical ventilation, the modern modes of ventilation presented here are further developments that optimize lung protection while improving pulmonary function and the synchrony of the patient with the ventilator. In high-frequency ventilation, tidal volumes of 1-2 mL/kgBW (body weight) are given, at a respiratory rate of up to 12 Hz. Assisted forms of spontaneous respiration are also in use, such as proportional assist ventilation (PAV), neurally adjusted ventilatory assist (NAVA), and variable pressure-support ventilation. Computer-guided closed-loop ventilation systems enable automated ventilation; according to a recent meta-analysis, they shorten weaning times by 32% . CONCLUSION: The currently available scientific evidence with respect to clinically relevant endpoints is inadequate for all of these newer modes of ventilation. It appears, however, that they can lower both the invasiveness and the duration of mechanical ventilation, and thus improve the care of patients who need ventilation. Randomized trials with clinically relevant endpoints must be carried out before any final judgments can be made.
BACKGROUND: Mechanical ventilation is a common and often life-saving intervention in intensive care medicine. About 35% of all patients in intensive care are mechanically ventilated; about 15% of these patients develop a ventilation-associated pneumonia. The goal of ventilation therapy is to lessen the work of respiration and pulmonary gas exchange and thereby maintain or restore an adequate oxygen supply to the body's tissues. Mechanical ventilation can be carried out in many different modes; the avoidance of ventilation-induced lung damage through protective ventilation strategies is currently a major focus of clinical interest. METHOD: This review is based on pertinent articles retrieved by a selective literature search. RESULTS: Compared to conventional lung-protecting modes of mechanical ventilation, the modern modes of ventilation presented here are further developments that optimize lung protection while improving pulmonary function and the synchrony of the patient with the ventilator. In high-frequency ventilation, tidal volumes of 1-2 mL/kgBW (body weight) are given, at a respiratory rate of up to 12 Hz. Assisted forms of spontaneous respiration are also in use, such as proportional assist ventilation (PAV), neurally adjusted ventilatory assist (NAVA), and variable pressure-support ventilation. Computer-guided closed-loop ventilation systems enable automated ventilation; according to a recent meta-analysis, they shorten weaning times by 32% . CONCLUSION: The currently available scientific evidence with respect to clinically relevant endpoints is inadequate for all of these newer modes of ventilation. It appears, however, that they can lower both the invasiveness and the duration of mechanical ventilation, and thus improve the care of patients who need ventilation. Randomized trials with clinically relevant endpoints must be carried out before any final judgments can be made.
Authors: Peter M Spieth; Alysson R Carvalho; Andreas Güldner; Paolo Pelosi; Oleg Kirichuk; Thea Koch; Marcelo Gama de Abreu Journal: Anesthesiology Date: 2009-02 Impact factor: 7.892
Authors: Peter M Spieth; Alysson R Carvalho; Paolo Pelosi; Catharina Hoehn; Christoph Meissner; Michael Kasper; Matthias Hübler; Matthias von Neindorff; Constanze Dassow; Martina Barrenschee; Stefan Uhlig; Thea Koch; Marcelo Gama de Abreu Journal: Am J Respir Crit Care Med Date: 2009-01-16 Impact factor: 21.405
Authors: Alysson R Carvalho; Peter M Spieth; Andreas Güldner; Maximilano Cuevas; Nadja C Carvalho; Alessandro Beda; Stephanie Spieth; Christian Stroczynski; Bärbel Wiedemann; Thea Koch; Paolo Pelosi; Marcelo Gama de Abreu Journal: J Appl Physiol (1985) Date: 2011-01-26
Authors: Laurent Papazian; Jean-Marie Forel; Arnaud Gacouin; Christine Penot-Ragon; Gilles Perrin; Anderson Loundou; Samir Jaber; Jean-Michel Arnal; Didier Perez; Jean-Marie Seghboyan; Jean-Michel Constantin; Pierre Courant; Jean-Yves Lefrant; Claude Guérin; Gwenaël Prat; Sophie Morange; Antoine Roch Journal: N Engl J Med Date: 2010-09-16 Impact factor: 91.245
Authors: Matthias Briel; Maureen Meade; Alain Mercat; Roy G Brower; Daniel Talmor; Stephen D Walter; Arthur S Slutsky; Eleanor Pullenayegum; Qi Zhou; Deborah Cook; Laurent Brochard; Jean-Christophe M Richard; Francois Lamontagne; Neera Bhatnagar; Thomas E Stewart; Gordon Guyatt Journal: JAMA Date: 2010-03-03 Impact factor: 56.272
Authors: Dave A Dongelmans; Frederique Paulus; Denise P Veelo; Jan M Binnekade; Margreeth B Vroom; Marcus J Schultz Journal: Anesthesiology Date: 2011-05 Impact factor: 7.892
Authors: Hannah Wunsch; Walter T Linde-Zwirble; Derek C Angus; Mary E Hartman; Eric B Milbrandt; Jeremy M Kahn Journal: Crit Care Med Date: 2010-10 Impact factor: 7.598
Authors: Frank Daniel Martos-Benítez; Andrés Soto-García; Anarelys Gutiérrez-Noyola Journal: J Cancer Res Clin Oncol Date: 2018-01-23 Impact factor: 4.553
Authors: Michael Grubmüller; Maximilian Kerschbaum; Eva Diepold; Katharina Angerpointner; Michael Nerlich; Antonio Ernstberger Journal: Scand J Trauma Resusc Emerg Med Date: 2018-01-08 Impact factor: 2.953